Capital Fund Management (CFM) Portfolio holdings
AUM
$9.06B
1-Year Return
3.46%
This Quarter Return
+1.99%
1 Year Return
+3.46%
3 Year Return
+12.89%
5 Year Return
+19.14%
10 Year Return
+34.42%
AUM
$5.1B
AUM Growth
+$575M
(+13%)
Cap. Flow
+$240M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
17.43%
Holding
959
New
163
Increased
171
Reduced
207
Closed
140
Top Buys
| 1 |
Apple
AAPL
|
+$133M |
| 2 |
PepsiCo
PEP
|
+$90.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$63.9M |
| 4 |
UnitedHealth
UNH
|
+$54.7M |
| 5 |
CVS Health
CVS
|
+$51.7M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$87.2M |
| 2 |
Valero Energy
VLO
|
+$73.3M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$65.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$64.7M |
| 5 |
Amazon
AMZN
|
+$39.7M |
Sector Composition
| 1 | Technology | 22.32% |
| 2 | Consumer Discretionary | 15.26% |
| 3 | Healthcare | 13.61% |
| 4 | Industrials | 9.3% |
| 5 | Consumer Staples | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Kilroy Realty
KRC
$4.98B
| $696K | ﹤0.01% |
+21,479
| New | +$696K |
|
477
Omega Healthcare
OHI
$12.6B
| $696K | ﹤0.01% |
+25,376
| New | +$696K |
|
478
EPR Properties
EPR
$4.19B
| $690K | ﹤0.01% |
18,106
-3,248
| -15% | -$124K |
|
|
AEL
479
DELISTED
American Equity Investment Life Holding Company
AEL
| $689K | ﹤0.01% |
+18,876
| New | +$689K |
|
480
Cenovus Energy
CVE
$30.7B
| $687K | ﹤0.01% |
39,337
-5,958
| -13% | -$104K |
|
481
Scotiabank
BNS
$79.4B
| $680K | ﹤0.01% |
13,503
-23,818
| -64% | -$1.2M |
|
482
Sally Beauty Holdings
SBH
$1.45B
| $675K | ﹤0.01% |
43,350
+19,115
| +79% | +$298K |
|
483
AXIS Capital
AXS
$7.59B
| $671K | ﹤0.01% |
+12,310
| New | +$671K |
|
484
iQIYI
IQ
$2.5B
| $650K | ﹤0.01% |
+89,353
| New | +$650K |
|
485
Evergy
EVRG
$16.5B
| $643K | ﹤0.01% |
+10,528
| New | +$643K |
|
|
HIMX
486
Himax Technologies
HIMX
$1.47B
| $597K | ﹤0.01% |
73,459
-2,242
| -3% | -$18.2K |
|
487
Shake Shack
SHAK
$3.92B
| $593K | ﹤0.01% |
10,687
-27,251
| -72% | -$1.51M |
|
488
Itron
ITRI
$5.41B
| $590K | ﹤0.01% |
+10,632
| New | +$590K |
|
489
Flowserve
FLS
$7.35B
| $589K | ﹤0.01% |
+17,324
| New | +$589K |
|
490
DigitalBridge
DBRG
$2.03B
| $585K | ﹤0.01% |
+48,789
| New | +$585K |
|
491
Akero Therapeutics
AKRO
$3.46B
| $583K | ﹤0.01% |
+15,231
| New | +$583K |
|
492
Tilray
TLRY
$1.2B
| $582K | ﹤0.01% |
230,140
+8,100
| +4% | +$20.5K |
|
493
Ultragenyx Pharmaceutical
RARE
$3.02B
| $577K | ﹤0.01% |
14,398
+1,081
| +8% | +$43.3K |
|
494
Zions Bancorporation
ZION
$8.56B
| $573K | ﹤0.01% |
+19,148
| New | +$573K |
|
495
Xerox
XRX
$456M
| $568K | ﹤0.01% |
36,860
-135,692
| -79% | -$2.09M |
|
496
CRISPR Therapeutics
CRSP
$4.71B
| $554K | ﹤0.01% |
12,241
-48,013
| -80% | -$2.17M |
|
497
BioCryst Pharmaceuticals
BCRX
$1.68B
| $545K | ﹤0.01% |
+65,294
| New | +$545K |
|
498
Masco
MAS
$15.3B
| $544K | ﹤0.01% |
10,938
-3,274
| -23% | -$163K |
|
|
VERV
499
DELISTED
Verve Therapeutics
VERV
| $535K | ﹤0.01% |
+37,093
| New | +$535K |
|
|
NATI
500
DELISTED
National Instruments Corp
NATI
| $532K | ﹤0.01% |
+10,153
| New | +$532K |
|